Fund moves
61 tracked managers disclosed the same change for Q4 2024. From a 13F filed Jan 2, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 29, 2024 · Filed Dec 3, 2024
The CFO of Gilead Sciences sold $11.2M of Gilead Sciences shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$11,198,151
Shares × reported transaction price
23 days after results of Nov 6, 2024, 74 days before results of Feb 11, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
A WARN layoff notice covering 72 workers was filed in Washington on November 13, 2024.
From the official state WARN list, 16 days before the trade. Shown for timing only; the two filings are separate
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
FDA approved Sunlenca on Nov 25, 2024, 4 days before this trade.
New use approved (efficacy supplement). Active ingredient: Lenacapavir Sodium. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.9% | 0.0% | +0.9% |
| 30 days | −0.2% | −2.6% | +2.4% |
| 90 days | +25.3% | −5.1% | +30.4% |
| 180 days | +18.9% | −2.5% | +21.4% |
| 365 days | +33.9% | +12.6% | +21.3% |
Past results only. Not a forecast.
Fund moves
61 tracked managers disclosed the same change for Q4 2024. From a 13F filed Jan 2, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Congress
Traded Dec 24, 2024 · disclosed 3 days later
4 different filers disclosed GILD within 90 days.
Andrew D Dickinson (Chief Financial Officer) sold ~$782K of Gilead Sciences
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.